PUBLISHER: The Business Research Company | PRODUCT CODE: 1946682
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946682
Orthopedic bone cement and casting materials are specialized medical substances used in orthopedic surgeries to stabilize fractures, promote bone healing, and aid in implant fixation. Bone cement is primarily used to anchor prosthetic joints and fill bone defects, providing structural stability and enhancing recovery. Casting materials serve to immobilize fractures, maintain proper bone alignment, and limit movement to ensure effective healing.
The primary products in this category include bone cement and casting materials. Bone cement, commonly composed of polymethyl methacrylate (PMMA), is a biomaterial utilized to secure implants and fill bone voids during orthopedic procedures. These products are made from various materials such as PMMA, calcium phosphate, plaster of Paris, fiberglass, and others, and come in several forms, including injectable options, prepackaged formulations, and injectable bone substitutes. They are used in a range of applications such as joint arthroplasty, trauma cases, sports injuries, and spinal surgeries. End users include hospitals, ambulatory surgical centers, orthopedic clinics, and other healthcare facilities.
Tariffs are impacting the orthopedic bone cement and casting materials market by increasing the cost of imported raw materials such as polymethyl methacrylate, calcium phosphate, and fiberglass. Segments like biodegradable bone cements and hybrid casting materials are particularly impacted, with Asia-Pacific regions including China and India facing high import duties. This has led to higher production costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing, innovation in alternative materials, and investment in domestic production capabilities.
The orthopedic bone cement and casting materials market research report is one of a series of new reports from The Business Research Company that provides orthopedic bone cement and casting materials market statistics, including orthopedic bone cement and casting materials industry global market size, regional shares, competitors with a orthopedic bone cement and casting materials market share, detailed orthopedic bone cement and casting materials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic bone cement and casting materials industry. This orthopedic bone cement and casting materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The orthopedic bone cement and casting materials market size has grown strongly in recent years. It will grow from $3.04 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to limited variety of bone cements, reliance on plaster of paris for casting, increasing orthopedic surgeries, growing hospital infrastructure, rising sports injury cases.
The orthopedic bone cement and casting materials market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to development of advanced injectable bone substitutes, increasing adoption of biodegradable and ceramic cements, rising demand for fiberglass and hybrid casting materials, growth in ambulatory surgical centers, technological advancements in minimally invasive orthopedic treatments. Major trends in the forecast period include rising use of polymethyl methacrylate (pmma) bone cement, increasing adoption of biodegradable and ceramic bone cements, growth in fiberglass and thermoplastic casting materials, rising demand in joint arthroplasty and trauma cases, enhanced focus on minimally invasive orthopedic procedures.
The growing incidence of road accidents is expected to drive the expansion of the orthopedic bone cement and casting materials market in the coming years. The rise in road accidents is largely attributed to distracted driving, where activities divert drivers' attention and slow reaction times, increasing the likelihood of collisions. Road accidents frequently result in fractures and bone injuries that require surgical intervention, along with the use of orthopedic materials such as bone cement for implant fixation and casting materials for fracture immobilization during the healing process. For example, according to GOV.UK, a UK-based government agency, motorcyclist fatalities increased by 8% between 2023 and 2024, while motorcyclist traffic rose by 4%. Therefore, the increasing incidence of road accidents is expected to boost the growth of the orthopedic bone cement and casting materials market.
Companies operating in the orthopedic bone cement and casting materials market are focusing on developing advanced products, such as antibiotic bone cement, to reduce the risk of post-surgical infections. Antibiotic bone cement is a polymethyl methacrylate (PMMA)-based material infused with antibiotics to prevent or treat infections during orthopedic procedures, particularly joint replacement surgeries. For instance, in March 2025, Zimmer Biomet, a US-based medical technology company, launched Tekcem 1G and Tekcem 3G antibiotic bone cement. These products incorporate gentamicin, an antibiotic that helps protect against infections during joint reconstruction and arthroplasty procedures, making them suitable for both primary and revision surgeries following trauma. Additionally, their low monomer release reduces toxicity and shrinkage, enhancing clinical safety and performance.
In September 2024, Biocomposites, a UK-based medical device company, acquired shares in Laboratorios SL and Synergie Ingenierie Medicale for an undisclosed amount. This acquisition gave Biocomposites full control of the SYNICEM and Subiton product ranges and supports its strategic objective to lead innovation in products designed for the treatment of bone and soft tissue infections. Laboratorios SL is a Spain-based company, while Synergie Ingenierie Medicale is a France-based manufacturer of orthopedic bone cement.
Major companies operating in the orthopedic bone cement and casting materials market are Zimmer Biomet Holdings Inc., Stryker Corporation, DePuy Synthes Inc., Smith & Nephew Plc, Heraeus Medical GmbH, Exactech Inc., Wright Medical Group N.V., DJO Global Inc., BSN Medical GmbH, 3M Health Care Ltd, Johnson & Johnson Services Inc., Medtronic plc, Aap Implantate AG, G21 S.r.l, Scanos, Teknimed S.A., Olympus Terumo Biomaterials Corp., Surgival S.A., Kyphon (Medtronic spine cement division), Cook Medical (bone substitute portfolio), Cementek S.p.A., Orthofix Medical Inc.
North America was the largest region in the orthopedic bone cement and casting materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthopedic bone cement and casting materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the orthopedic bone cement and casting materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The orthopedic bone cement and casting materials market consists of sales of bioresorbable bone cement, radiopaque bone cement, bone cement spacer and casting tapes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Orthopedic Bone Cement And Casting Materials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses orthopedic bone cement and casting materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for orthopedic bone cement and casting materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic bone cement and casting materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.